Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1891)	2/7/1999 10:44:00 PM
From: Walter Morton	Read Replies (2) \| Respond to of 2742

Genomes contract is over in April and HMGN is too price for CIST to buy now. CIST has a board member that does the same thing that Genome does.

To: Dr. John M. de Castro who wrote (1891)	2/8/1999 2:07:00 PM
From: Steve Harmon	Respond to of 2742

$1,000,000 equals what the 2 managers left at Cistron have been paid since the IMNX settlement. $1,000,000 equals a 4 million share buyback in the open market. Shareholders value is "increased"... Who has been "enhanced"?